Authors:
KOBAYASHI S
YAMAGUCHI T
OTSUJI E
MATSUMURA H
TSURUTA H
YATA Y
NISHI Y
OKAMOTO K
TAKAHASHI T
Citation: S. Kobayashi et al., BIODISTRIBUTION OF MURINE AND CHIMERIC FAB FRAGMENTS OF THE MONOCLONAL-ANTIBODY A7 IN HUMAN PANCREATIC-CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 27-27
Authors:
MATSUMURA H
YAMAGUCHI T
OTSUJI E
KOBAYASHI S
TSURUTA H
YATA Y
NISHI H
OKAMOTO K
TAKAHASHI T
Citation: H. Matsumura et al., INCREASED EFFECTS OF NEOCARZINOSTATIN-CHIMERIC FAB CONJUGATES ON THE GROWTH OF HUMAN PANCREATIC-CARCINOMA XENOGRAFTS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 29-29
Authors:
NISHI H
YAMAGUCHI T
OTSUJI E
OKAMOTO K
YATA Y
TSURUTA H
MATSUMURA H
KOBAYASHI S
TAKAHASHI T
Citation: H. Nishi et al., ENHANCED IMMUNOSCINTIGRAPHY OF COLONIC-CANCER WITH BIOTINYLATED MONOCLONAL-ANTIBODY A7 AND AVIDIN, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 31-31
Authors:
OKAMOTO K
YAMAGUCHI T
OTSUJI E
YAMAOKA N
KOBAYASHI S
MATSUMURA H
YATA Y
TSURUTA H
KITAMURA K
TAKAHASHI T
Citation: K. Okamoto et al., MISSILE CANCER-CHEMOTHERAPY OF GASTRIC-CANCER WITH PERITONEAL DISSEMINATION, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 33-33
Authors:
OTSUJI E
YAMAGUCHI T
KOBAYASHI S
MATSUMURA H
TSURUTA H
YATA Y
NISHI H
OKAMOTO K
TAKAHASHI T
Citation: E. Otsuji et al., DECREASED RENAL ACCUMULATION OF BIOTINYLATED CHIMERIC MONOCLONAL ANTIBODY-NEOCARZINOSTATIN CONJUGATE AFTER ADMINISTRATION OF AVIDIN, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 34-34
Authors:
TSURUTA H
YAMAGUCHI T
OTSUJI E
KOBAYASHI S
MATSUMURA H
YATA Y
NISHI H
OKAMOTO K
TAKAHASHI T
Citation: H. Tsuruta et al., APPLICATION OF TUMOR-SPECIFIC MONOCLONAL-ANTIBODY A7 - MAGNETIC IRON-OXIDE PARTICLE CONJUGATE FOR IMMUNOGUIDED SURGERY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 40-40
Authors:
YAMAGUCHI T
KITAMURA K
OTSUJI E
OKAMOTO K
TSURUTA H
MATSUMURA H
NISHI H
NISHIDA S
YAMAMOTO K
TANIGUCHI K
YATA Y
MIYAGAKI T
KOBAYASHI S
TAKAHASHI T
Citation: T. Yamaguchi et al., COMPARATIVE-STUDY OF RADIOIMAGING OF COLORECTAL-CANCER USING MOUSE WHOLE ANTIBODY, F(AB')2 FRAGMENT OF MOUSE MONOCLONAL-ANTIBODY AND FAB FRAGMENT OF HUMAN MOUSE CHIMERIC ANTIBODY/, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 42-42
Authors:
YATA Y
YAMAGUCHI T
KITAMURA K
OTSUJI E
OKAMOTO K
TSURUTA H
TAKAHASHI T
Citation: Y. Yata et al., HUMAN MOUSE CHIMERIC MONOCLONAL FRAGMENT NEOCARZINOSTATIN CONJUGATE -KINETICS AND IMMUNE-RESPONSE/, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 43-43
Authors:
AIBA N
MORIOKA J
MIYAZONO T
OKITA H
YATA Y
OKADA K
NAMBU S
WATANABE A
SHIMIZU M
FUJIMURA M
IZUMI R
Citation: N. Aiba et al., CASE-REPORT - INTRAHEPATIC PORTAL-HEPATIC VENOUS SHUNTS ASSOCIATED WITH A HUGE PELVIC LEIOMYOMA, Journal of gastroenterology and hepatology, 13(2), 1998, pp. 158-162
Authors:
YAMAGUCHI T
YAMAOKA N
KITAMURA K
OTSUJI E
OKAMOTO K
TSURUTA H
YATA Y
TAKAHASHI T
Citation: T. Yamaguchi et al., CHANGES IN EXPRESSION OF THE ANTIGEN RECOGNIZED BY MONOCLONAL-ANTIBODY A7 IN HUMAN PANCREATIC-CARCINOMA CELLS FOLLOWING EXPOSURE TO ANTICANCER AGENTS, Cancer letters, 126(2), 1998, pp. 165-172
Authors:
OKAMOTO K
YAMAGUCHI T
OTSUJI E
YAMAOKA N
YATA Y
TSURUTA H
KITAMURA K
TAKAHASHI T
Citation: K. Okamoto et al., TARGETED CHEMOTHERAPY IN MICE WITH PERITONEALLY DISSEMINATED GASTRIC-CANCER USING MONOCLONAL ANTIBODY-DRUG CONJUGATE, Cancer letters, 122(1-2), 1998, pp. 231-236
Authors:
OTSUJI E
YAMAGUCHI T
YAMAMOTO K
MATSUMURA H
TSURUTA H
YATA Y
NISHI H
OKAMOTO K
KITAMURA K
TAKAHASHI T
Citation: E. Otsuji et al., DECREASED RENAL ACCUMULATION OF BIOTINYLATED CHIMERIC MONOCLONAL ANTIBODY-NEOCARZINOSTATIN CONJUGATE AFTER ADMINISTRATION OF AVIDIN, Japanese journal of cancer research, 88(2), 1997, pp. 205-212
Authors:
YOSHIDA K
MINEGISHI Y
OKAWA H
YATA Y
TOKOI S
KITAGAWA T
UTAGAWA T
Citation: K. Yoshida et al., EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANT-LYMPHOMA WITH MACROAMYLASEMIAAND MONOCLONAL GAMMOPATHY IN A PATIENT WITH WISKOTT-ALDRICH SYNDROME, Pediatric hematology and oncology, 14(1), 1997, pp. 85-89
Authors:
NISHI H
YAMAGUCHI T
OTSUJI E
KOTANI T
TANIGUCHI K
OKAMOTO K
YATA Y
TSURUTA H
TAKAHASHI T
Citation: H. Nishi et al., REDUCED BLOOD ACCUMULATION OF BIOTINYLATED MONOCLONAL-ANTIBODY A7 AFTER THE SUBSEQUENT ADMINISTRATION OF AVIDIN, Cancer letters, 120(2), 1997, pp. 127-134
Authors:
TAKAHARA T
FURUI K
YATA Y
JIN B
ZHANG LP
NAMBU S
SATO H
SEIKI M
WATANABE A
Citation: T. Takahara et al., DUAL EXPRESSION OF MATRIX METALLOPROTEINASE-2 AND MEMBRANE-TYPE-1 - MATRIX METALLOPROTEINASE IN FIBROTIC HUMAN LIVERS, Hepatology, 26(6), 1997, pp. 1521-1529
Authors:
TAKAHARA T
FURUI K
YATA Y
ZHANG LP
JIN B
NAMBU S
WATANABE A
Citation: T. Takahara et al., DUAL EXPRESSION OF MATRIX METALLOPROTEINASE-2 AND MEMBRANE-TYPE-1-MATRIX METALLOPROTEINASE IN FIBROTIC HUMAN LIVERS, Hepatology, 26(4), 1997, pp. 1285-1285
Authors:
AIBA N
OKITA H
YATA Y
OKADA K
FURUI K
NAMBU S
MIYAGIWA M
WATANABE A
Citation: N. Aiba et al., CLASSIFICATION OF NONCIRRHOTIC HEPATIC-ENCEPHALOPATHY DUE TO ENORMOUSPORTAL-SYSTEMIC SHUNT, Hepatology, 26(4), 1997, pp. 1365-1365
Citation: S. Nambu et al., CIRCULATING ALPHA-FETOPROTEIN MESSENGER-RNA AND ITS CLINICAL-SIGNIFICANCE IN HUMAN HEPATOCELLULAR-CARCINOMA IN EARLY-STAGE, Hepatology, 26(4), 1997, pp. 1770-1770
Authors:
YATA Y
TAKAHARA T
FURUI K
ZHANG LP
JIN B
WATANABE A
Citation: Y. Yata et al., INTERFERON-GAMMA TREATMENT IMPROVES LIVER FIBROSIS THROUGH SUPPRESSEDGENE EXPRESSIONS OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR OFMETALLOPROTEINASES, Hepatology, 26(4), 1997, pp. 2013-2013
Authors:
OTSUJI E
YAMAGUCHI T
TSURUTA H
YATA Y
NISHI H
OKAMOTO K
TANIGUCHI K
KATO M
KOTANI T
KITAMURA K
TAKAHASHI T
Citation: E. Otsuji et al., APPLICABILITY OF MONOCLONAL-ANTIBODY FAB FRAGMENTS AS A CARRIER OF NEOCARZINOSTATIN IN TARGETING CHEMOTHERAPY, Journal of surgical oncology, 61(2), 1996, pp. 149-154
Authors:
OTSUJI E
YAMAGUCHI T
MATSUMURA H
YAMAMOTO K
TSURUTA H
YATA Y
NISHI H
OKAMOTO K
KITAMURA K
TAKAHASHI T
Citation: E. Otsuji et al., DISTRIBUTION OF NEOCARZINOSTATIN CONJUGATED TO BIOTINYLATED CHIMERIC MONOCLONAL-ANTIBODY FAB FRAGMENTS AFTER ADMINISTRATION OF AVIDIN, British Journal of Cancer, 74(4), 1996, pp. 597-602
Authors:
OTSUJI E
YAMAGUCHI T
TSURUTA H
YATA Y
NISHI H
OKAMOTO K
TANIGUCHI K
KATO M
KOTANI T
KITAMURA K
TAKAHASHI T
Citation: E. Otsuji et al., EFFECTS OF NEOCARZINOSTATIN - CHIMERIC FAB CONJUGATES ON THE GROWTH OF HUMAN PANCREATIC-CARCINOMA XENOGRAFTS, British Journal of Cancer, 73(10), 1996, pp. 1178-1182
Citation: A. Watanabe et al., EVALUATION OF NEUROPSYCHOLOGICAL FUNCTION IN PATIENTS WITH LIVER-CIRRHOSIS WITH SPECIAL REFERENCE TO THEIR DRIVING ABILITY, Metabolic brain disease, 10(3), 1995, pp. 239-248
Authors:
OTSUJI E
YAMAGUCHI T
YATA Y
NISHI H
OKAMOTO K
TANIGUCHI K
KATO M
KOTANI T
YAMAOKA N
KITAMURA K
TAKAHASHI T
Citation: E. Otsuji et al., ANTITUMOR EFFECT OF NEOCARZINOSTATIN CONJUGATED TO HUMAN MOUSE CHIMERIC FAB FRAGMENTS OF THE MONOCLONAL-ANTIBODY A7 ON HUMAN PANCREATIC-CARCINOMA, Journal of surgical oncology, 57(4), 1994, pp. 230-234